1 FDA Guidance on Hemp Product Development
-
In Sep 2018, FDA approved Epidiolex (Cannabidiol) Primer, the first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication, to treat Dravet syndrome or Lennox-Gastaut syndrome.
-
In Feb 2020, FDA issued an opinion to encourage cannabis companies to develop cannabis products to prescription drugs through botanical drug development guidance for industry.
-
In July 2020, FDA developed a draft GFI "Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry"
